Sesen Bio, Inc. (SESN)
USD 0.63
(7.29%)
USD 0.63
(7.29%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.89 Million | -68.87 Million | -30.83 Million | -37.52 Million | -22.82 Million | -17.76 Million |
| Net Income | -19.88 Million | -336 Thousand | -22.39 Million | -107.5 Million | -33.69 Million | -29.02 Million |
| Depreciation & Amortization | 13 Thousand | 85 Thousand | 122 Thousand | 219 Thousand | 208 Thousand | 285 Thousand |
| Deferred income taxes | - | 31.7 Million | - | - | -5000.00 | -113 Thousand |
| Stock-based compensation | 6.9 Million | 5.14 Million | 1.75 Million | 1.23 Million | 1.28 Million | 1.38 Million |
| Change in working capital | 63 Million | -48.63 Million | 861 Thousand | -3.09 Million | 578 Thousand | 611 Thousand |
| Other non-cash items | -25.14 Million | -56.84 Million | -11.18 Million | 71.62 Million | 8.8 Million | 8.98 Million |
| Investing Cash Flow | -53.96 Million | -4000.00 | -8000.00 | -136 Thousand | -2000.00 | 98 Thousand |
| Investments in PPE | - | -4000.00 | -8000.00 | -136 Thousand | -2000.00 | 98 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -128.99 Million | - | - | - | - | - |
| Sales/Maturities of investments | 75 Million | - | - | - | - | - |
| Other Investing Activities | 30 Thousand | -4000.00 | - | - | - | - |
| Financing Cash Flow | 1000.00 | 176.12 Million | 38.11 Million | 35.35 Million | 58.58 Million | 7 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 2.67 Million |
| Common Stock Issuance | 1000.00 | 174.96 Million | 37.95 Million | 29.76 Million | 58.28 Million | 6.9 Million |
| Other Financing Activities | 1000.00 | 1.16 Million | 302 Thousand | 5.58 Million | 297 Thousand | 97 Thousand |
| Accounts receivables | 21.01 Million | -24.49 Million | - | - | - | - |
| Accounts payables | -1.62 Million | -249 Thousand | 1.2 Million | 535 Thousand | 460 Thousand | -760 Thousand |
| Inventory | - | -22.38 Million | - | - | - | - |
| Other working capital | 43.61 Million | -1.5 Million | -339 Thousand | -3.63 Million | 118 Thousand | 1.37 Million |
| Cash at beginning of period | 162.65 Million | 55.4 Million | 48.14 Million | 50.44 Million | 14.69 Million | 25.34 Million |
| Cash at end of period | 133.58 Million | 162.65 Million | 55.4 Million | 48.14 Million | 50.44 Million | 14.68 Million |
| Capital Expenditure | - | -4000.00 | -8000.00 | -136 Thousand | -2000.00 | 98 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -29.07 Million | 107.24 Million | 7.26 Million | -2.3 Million | 35.75 Million | -10.66 Million |
| Free Cash Flow | 24.89 Million | -68.88 Million | -30.84 Million | -37.65 Million | -22.83 Million | -17.66 Million |
| Breakdown | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.64 Million | -7.57 Million | -19.88 Million | 20.45 Million | -31.96 Million | -807 Thousand |
| Depreciation & Amortization | 705 Thousand | -13.9 Thousand | 13 Thousand | - | 3000.00 | 10 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 265 Thousand | 1.04 Million | 6.9 Million | 2.16 Million | 1.8 Million | 1.89 Million |
| Change in working capital | 2.82 Million | 9.88 Million | 63 Million | 2.78 Million | 31.37 Million | 18.95 Million |
| Other non-cash items | -4.68 Million | -664.1 Thousand | -25.14 Million | -1.75 Million | -9.81 Million | -12.9 Million |
| Investing Cash Flow | -3.59 Million | 59.76 Million | -53.96 Million | -24.63 Million | -89.09 Million | - |
| Investments in PPE | -135 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -34.46 Million | -15.23 Million | -128.99 Million | -24.66 Million | -89.09 Million | - |
| Sales/Maturities of investments | 31 Million | 75 Thousand | 75 Million | - | - | - |
| Other Investing Activities | - | 74.92 Million | 30 Thousand | 30 Thousand | - | - |
| Financing Cash Flow | 67.74 Million | 1000.00 | 1000.00 | - | - | - |
| Debt repayment | -151 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 30.64 Million | 1000.00 | 1000.00 | - | - | - |
| Other Financing Activities | 37.25 Million | - | 1000.00 | - | - | - |
| Accounts receivables | - | -2000.00 | 21.01 Million | 73 Thousand | 939 Thousand | 20 Million |
| Accounts payables | 2.82 Million | 719 Thousand | -1.62 Million | -1.15 Million | 1 Million | -2.18 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.82 Million | 9.17 Million | 43.61 Million | 3.86 Million | 29.43 Million | 1.14 Million |
| Cash at beginning of period | 24.19 Million | 71.13 Million | 162.65 Million | 72.12 Million | 169.81 Million | 162.65 Million |
| Cash at end of period | 62.8 Million | 133.58 Million | 133.58 Million | 71.13 Million | 72.12 Million | 169.81 Million |
| Capital Expenditure | -135 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 38.61 Million | 62.44 Million | -29.07 Million | -983 Thousand | -97.69 Million | 7.15 Million |
| Free Cash Flow | -25.66 Million | 2.68 Million | 24.89 Million | 23.65 Million | -8.59 Million | 7.15 Million |
ATMCW
LVVV
AEXFF
CRVO
CRGX
HXL